Instrumentos de avaliação de intenção empreendedora: uma revisão de literatura

Autor: Pedro Alfonso Cortez, Mg., Nelson Hauck Filho, Dr.

Publikováno v: Cuadernos Latinoamericanos de Administración, Vol 16, Iss 30 (2020)

Los modelos de intención emprendedora ayudan en la comprensión de las creencias individuales relacionadas con iniciar el propio negocio. Aunque todavía reciente en la literatura nacional, la evaluación de la intención emprendedora ha sido conduc

Externí odkaz: https://doaj.org/article/3f62b8863d3943529c4f58d73c21f3d5

Authors' reply to: Comment on the article by Dr. N. Shakrawal: Barrier device prototype for open tracheotomy during COVID-19 pandemic.

Autor: Filho, Dr. Wellington Alves¹ (AUTHOR) wellington.alves@ebserh.gov.br

Publikováno v: Auris Nasus Larynx. Feb2021, Vol. 48 Issue 1, p177-177. 1p.

Tumor spread through air spaces in lung cancer: prospective analysis of the accuracy of intraoperative frozen section examination.

Autor: Almeida GL; Hospital Geral de Caxias do Sul, Universidade de Caxias do Sul, Caxias do Sul (RS) Brasil., Pinto BM; Hospital Geral de Caxias do Sul, Universidade de Caxias do Sul, Caxias do Sul (RS) Brasil., Pinto VM; Hospital Geral de Caxias do Sul, Universidade de Caxias do Sul, Caxias do Sul (RS) Brasil., Tregnago AC; Hospital Geral de Caxias do Sul, Universidade de Caxias do Sul, Caxias do Sul (RS) Brasil., Almeida RF; Hospital Geral de Caxias do Sul, Universidade de Caxias do Sul, Caxias do Sul (RS) Brasil., Pinto Filho DR; Hospital Geral de Caxias do Sul, Universidade de Caxias do Sul, Caxias do Sul (RS) Brasil.

Publikováno v: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia [J Bras Pneumol] 2024 Sep 27; Vol. 50 (4), pp. e20240165. Date of Electronic Publication: 2024 Sep 27 (Print Publication: 2024).

TLR4 deficiency upregulates TLR9 expression and enhances irinotecan-related intestinal mucositis and late-onset diarrhoea.

Autor: Wong DVT; Graduate Program in Pathology, Department of Pathology and Forensic Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil.; Laboratory of Molecular Biology and Genetics, Haroldo Juaçaba Hospital, Cancer Institute of Ceará (ICC), Fortaleza, Ceará, Brazil., Holanda RBF; Graduate Program in Pharmaceutical Sciences, Department of Pharmacy, Faculty of Pharmacy, Nursing and Dentistry, Federal University of Ceará, Fortaleza, Ceará, Brazil., Cajado AG; Laboratory of Inflammation and Cancer Pharmacology, Drug Research and Development Center (NPDM), Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Ceará, Brazil., Bandeira AM; Laboratory of Inflammation and Cancer Pharmacology, Drug Research and Development Center (NPDM), Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Ceará, Brazil., Pereira JFB; Laboratory of Inflammation and Cancer Pharmacology, Drug Research and Development Center (NPDM), Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Ceará, Brazil., Amorim JO; Laboratory of Molecular Biology and Genetics, Haroldo Juaçaba Hospital, Cancer Institute of Ceará (ICC), Fortaleza, Ceará, Brazil., Torres CS; Laboratory of Inflammation and Cancer Pharmacology, Drug Research and Development Center (NPDM), Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Ceará, Brazil., Ferreira LMM; Laboratory of Inflammation and Cancer Pharmacology, Drug Research and Development Center (NPDM), Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Ceará, Brazil., Lopes MHS; Graduate Program in Pathology, Department of Pathology and Forensic Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil., Oliveira RTG; Cancer Cytogenomic Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, Ceará, Brazil., Pereira AF; Laboratory of Inflammation and Cancer Pharmacology, Drug Research and Development Center (NPDM), Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Ceará, Brazil., Sant'Ana RO; Laboratory of Molecular Biology and Genetics, Haroldo Juaçaba Hospital, Cancer Institute of Ceará (ICC), Fortaleza, Ceará, Brazil.; Clinical Oncology Service, Haroldo Juaçaba Hospital, Cancer Institute of Ceará (ICC), Fortaleza, Ceará, Brazil., Arruda LM; Clinical Oncology Service, Haroldo Juaçaba Hospital, Cancer Institute of Ceará (ICC), Fortaleza, Ceará, Brazil., Ribeiro-Júnior HL; Cancer Cytogenomic Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, Ceará, Brazil., Pinheiro RF; Cancer Cytogenomic Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, Ceará, Brazil., Almeida PRC; Graduate Program in Pathology, Department of Pathology and Forensic Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil., Carvalho RF; Department of Structural and Functional Biology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil., Chaves FF; Clinical Oncology Service, Haroldo Juaçaba Hospital, Cancer Institute of Ceará (ICC), Fortaleza, Ceará, Brazil., Rocha-Filho DR; Clinical Oncology Service, Walter Cantídio University Hospital, Federal University of Ceará, Fortaleza, Ceará, Brazil., Cunha FQ; Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, São Paulo, State of São Paulo, Brazil., Lima-Júnior RCP; Laboratory of Inflammation and Cancer Pharmacology, Drug Research and Development Center (NPDM), Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Ceará, Brazil.

Publikováno v: British journal of pharmacology [Br J Pharmacol] 2021 Oct; Vol. 178 (20), pp. 4193-4209. Date of Electronic Publication: 2021 Aug 01.

Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of oesophageal cancer.

Autor: Rocha-Filho DR; Hospital Universitário Walter Cantídio, 60430-372 Fortaleza, Brazil.; Grupo Oncologia D'Or, 04535-110 São Paulo, Brazil., Peixoto RD; Grupo Oncoclínicas, 04543-906 São Paulo, Brazil., Weschenfelder RF; Hospital Moinhos de Vento, 90035-000 Porto Alegre, Brazil., Rego JFM; Hospital Universitário Onofre Lopes, 59012-300 Natal, Brazil., Riechelmann R; AC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil., Coutinho AK; Clínica AMO, 41.950-640 Salvador, Brazil., Fernandes GS; Hospital Sírio Libanês, 01308-050 São Paulo, Brazil., Jacome AA; Grupo Oncoclínicas, 04543-906 São Paulo, Brazil., Andrade AC; Grupo Oncoclínicas, 04543-906 São Paulo, Brazil., Murad AM; Laboratório Personal, 30130-090 Fortaleza, Brazil., Mello CAL; AC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil., Miguel DSCG; Clínica AMO, 41.950-640 Salvador, Brazil., Gomes DBD; Hospital Israelita Albert Einstein, 05652-900, São Paulo, Brazil., Racy DJ; Hospital Beneficência Portuguesa de São Paulo, 01323-001 São Paulo, Brazil., Moraes ED; Grupo Oncoclínicas, 04543-906 São Paulo, Brazil., Akaishi EH; Faculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil., Carvalho ES; Hospital São Rafael, 41253-190 Salvador, Brazil., Mello ES; Faculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil., Filho FM; Faculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil., Coimbra FJF; AC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil., Capareli FC; Hospital Sírio Libanês, 01308-050 São Paulo, Brazil., Arruda FF; Hospital Sírio Libanês, 01308-050 São Paulo, Brazil., Vieira FMAC; Américas Oncologia, 22775-001 Rio de Janeiro, Brazil., Takeda FR; Faculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil., Cotti GCC; Hospital Sírio Libanês, 01308-050 São Paulo, Brazil., Pereira GLS; Centro de Oncologia do Paraná, 81200-100 Curitiba, Brazil., Paulo GA; Universidade Federal de São Paulo, 04040-003 São Paulo, Brazil., Ribeiro HSC; AC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil., Lourenco LG; Universidade Federal de São Paulo, 04040-003 São Paulo, Brazil., Crosara M; Grupo Oncologia D'Or, 04535-110 São Paulo, Brazil., Toneto MG; Hospital São Lucas da PUCRS, 90610-000 Porto Alegre, Brazil., Oliveira MB; Faculdade de Ciências Médicas da Santa Casa de São Paulo, 01238-010 São Paulo, Brazil., de Lourdes Oliveira M; Grupo Oncologia D'Or, 04535-110 São Paulo, Brazil., Begnami MD; AC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil., Forones NM; Universidade Federal de São Paulo, 04040-003 São Paulo, Brazil., Yagi O; Faculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil., Ashton-Prolla P; Hospital de Clínicas de Porto Alegre, 90035-903 Porto Alegre, Brazil., Aguillar PB; Hospital Alemão Oswaldo Cruz, 01323-020 São Paulo, Brazil., Amaral PCG; Clínica AMO, 41.950-640 Salvador, Brazil., Hoff PM; Grupo Oncologia D'Or, 04535-110 São Paulo, Brazil., Araujo RLC; Universidade Federal de São Paulo, 04040-003 São Paulo, Brazil., Di Paula Filho RP; Hospital Alemão Oswaldo Cruz, 01323-020 São Paulo, Brazil., Gansl RC; Grupo Oncoclínicas, 04543-906 São Paulo, Brazil., Gil RA; Grupo Oncoclínicas, 04543-906 São Paulo, Brazil., Pfiffer TEF; Hospital Sírio Libanês, 01308-050 São Paulo, Brazil., Souza T; Hospital Aliança de Salvador, 41920-900 Salvador, Brazil., Ribeiro U Jr; Faculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil., Jesus VHF; AC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil., Costa WL Jr; AC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil., Prolla G; Grupo Oncoclínicas, 04543-906 São Paulo, Brazil.

Publikováno v: Ecancermedicalscience [Ecancermedicalscience] 2021 Mar 02; Vol. 15, pp. 1195. Date of Electronic Publication: 2021 Mar 02 (Print Publication: 2021).